Shannon L. Primm
Research Subjects
Research Interests
Shannon L. Primm has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Anthony Mannion
Division of Comparative Medicine, Massachusetts Institute of Technology
1 shared publication - Cory Brayton
Johns Hopkins University
1 shared publication - Courtney Lunger
Division of Comparative Medicine Massachusetts Institute of Technology Cambridge Massachusetts USA
1 shared publication - Isabel Angelica Jimenez
Department of Molecular and Comparative Pathobiology, School of Medicine, Johns Hopkins University, Baltimore, MD
1 shared publication - James G. Fox
Division of Comparative Medicine, Massachusetts Institute of Technology
1 shared publication - Jessica M. Izzi
Department of Molecular and Comparative Pathobiology Johns Hopkins University School of Medicine Baltimore Maryland USA
1 shared publication
Latest Publications
- Open Access
- 19 June 2026
- Published by Wiley in Journal of Medical Primatology
- Vol. 55 (4) , e70095
Clinical Management of Helicobacter Infection in Captive Baboons ( Papio anubis and Papio hamadryas ), and Isolation and Molecular Characterization of Three Novel Helicobacter Species
Background: Helicobacter spp. are gastric or enterohepatic bacteria that can be commensal, opportunistic, or pathogenic. Few studies have evaluated Helicobacter spp. in baboons. Methods: Twenty‐seven captive baboons were surveyed for Helicobacter spp. by fecal PCR, and a subset evaluated by culture. Nine baboons were treated with oral “triple therapy” with clarithromycin (10 mg/kg), amoxicillin (10 mg/kg), and omeprazole (20 mg) once daily for 10 days. Results: All baboons were positive for Helicobacter spp., including H. macacae (78%), H. suis (19%), and H. pylori (15%). Three novel Helicobacter species were identified by whole genomic sequencing, for which we propose the names Helicobacter papionis , H. simiae , and H. papionifaecis. Treatment was safe and effective for H. pylori , H. suis , and H. macacae , but did not eliminate the novel Helicobacter spp. Conclusions: Species‐specific assays should guide treatment of Helicobacter spp. infections in baboons. Further epidemiologic studies are needed to inform clinical management.
- 19 June 2026
- Published by Wiley in Journal of Medical Primatology
- Vol. 55 (4) , e70095
Open AccessClinical Management of Helicobacter Infection in Captive Baboons ( Papio anubis and Papio hamadryas ), and Isolation and Molecular Characterization of Three Novel Helicobacter Species
Background: Helicobacter spp. are gastric or enterohepatic bacteria that can be commensal, opportunistic, or pathogenic. Few studies have evaluated Helicobacter spp. in baboons. Methods: Twenty‐seven captive baboons were surveyed for Helicobacter spp. by fecal PCR, and a subset evaluated by culture. Nine baboons were treated with oral “triple therapy” with clarithromycin (10 mg/kg), amoxicillin (10 mg/kg), and omeprazole (20 mg) once daily for 10 days. Results: All baboons were positive for Helicobacter spp., including H. macacae (78%), H. suis (19%), and H. pylori (15%). Three novel Helicobacter species were identified by whole genomic sequencing, for which we propose the names Helicobacter papionis , H. simiae , and H. papionifaecis. Treatment was safe and effective for H. pylori , H. suis , and H. macacae , but did not eliminate the novel Helicobacter spp. Conclusions: Species‐specific assays should guide treatment of Helicobacter spp. infections in baboons. Further epidemiologic studies are needed to inform clinical management.